-
Signant Health Joins the Association of Clinical Research Organizations (ACRO) to Add a Technology Perspective to Industry Conversations
Nov 27, 2019, 11:09 AM by Michael CroftPHILADELPHIA, PA - Nov 27, 2019 - Signant Health announced today that it has joined the non-profit Association of Clinical Research Organizations (ACRO)Full story -
HudsonAlpha, Vanderbilt, Thermo Scientific, and More: News From November 2019
Nov 27, 2019, 08:40 AM by Michael CroftFull storyBio-IT World | November featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including HudsonAlpha, Vanderbilt, Thermo Scientific, and more.
-
Prokarium announces MHRA acceptance to run Phase I trial of lead vaccine against enteric fever
Nov 26, 2019, 04:50 AM by Michael CroftLONDON, UK - Nov 26, 2019 - Prokarium, a private biotechnology company developing vaccines against infectious diseases and immunotherapy for solid tumors, has received Clinical Trial Authorization (CTA) acceptance from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to run a first-in-human Phase I trial with Entervax, a bivalent vaccine against enteric feverFull story -
SAKOR Technologies Announces Dynamometer Line for Testing Electric Motor Efficiency to Meet International Environmental Standards
Nov 25, 2019, 14:27 PM by Michael CroftOWOSSO, MI, UNITED STATES - Nov 25, 2019 - For Immediate ReleaseContact: Judi Handel McNeil, Gray & Rice 617-367-0100 extFull story -
Explosion Of Interest In Organ-On-A-Chip Technology
Nov 25, 2019, 09:05 AM by Michael CroftFull storyBio-IT World | Organ-on-a-chip models were practically nonexistent a decade ago, but significant advances are now being made every few months.
-
Debiopharm Implements Dotmatics to Improve Data-Driven Decision-Making
Nov 25, 2019, 06:10 AM by Michael CroftBISHOP'S STORTFORD, UNITED KINGDOM - Nov 25, 2019 - Debiopharm International SA, the drug development company focused on oncology and infectious diseases, has implemented tools from Dotmatics, a leading provider of scientific informatics solutions and services, to re-engineer its data management processes to support its continuous growthFull story -
Potential findings on whole genome sequencing for cancer treatment was made
Nov 24, 2019, 16:39 PM by Michael CroftSHIRLEY, NY, UNITED STATES - Nov 25, 2019 - In recent years, individualized treatments will benefit more cancer patients as the time and cost of whole genome sequencing decreasesFull story -
Follow The Money: Investments and Funding Rounds for November
Nov 22, 2019, 14:30 PM by Michael CroftFull storyBio-IT World | Some of the latest funding updates from across life sciences, clinical trials, the diagnostics industries.
-
Hesperos: A CRO For Body-On-A-Chip Enthusiasts
Nov 22, 2019, 08:00 AM by Michael CroftFull storyBio-IT World | Operationally, Hesperos works much like a contract research organization that delivers study results back to sponsoring companies, with its specialty being integration assistance to drug developers interested in using a multiorgan model for their preclinical efficacy and toxicity studies.
-
Spring Bank Announces Dosing of Patients in Phase 1 Clinical Trial of IV-Administered STING Agonist, SB 11285
Nov 21, 2019, 09:42 AM by Michael CroftHOPKINTON, MA, UNITED STATES - Nov 20, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced that it has initiated dosing patients in a Phase 1 trial of SB 11285, the companys intravenously (IV)-administered STING (STimulator of INterferon Gene) agonistFull story -
Certara Announces the Availability of PK Submit, its Pharmacokinetic CDISC Technology Solution
Nov 21, 2019, 09:03 AM by Michael CroftPRINCETON, NJ - Nov 21, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the availability of PK Submit, a technology solution for automating the creation of PK Clinical Data Interchange Standards Consortium (CDISC) domains during Non-Compartmental Analysis (NCA)Full story -
Organs On Chips Will Make Drugs Safer—And More Precise
Nov 21, 2019, 06:45 AM by Michael CroftFull storyBio-IT World | The emergence of organ-on-a-chip systems to expedite drug discovery and toxicology studies is a process more than three decades in the making.
-
Elsevier joins forces with Food and Drug Administration to build predictive drug-induced liver injury AI algorithm
Nov 21, 2019, 05:42 AM by Michael CroftNEW YORK, NY - Nov 21, 2019 - Elsevier, a global information analytics business specializing in science and health, has entered into a Collaborative Research and Development Agreement (CRADA) with the National Center for Toxicological Research (NCTR) at the Food and Drug Administration (FDA)Full story -
Creative Proteomics Has Made Targeted Metabolomics Service More Perfect
Nov 21, 2019, 01:33 AM by Michael CroftSHIRLEY, NY - Nov 21, 2019 - November 21, 2019, as an integrated company and leading supplier in the field of proteomics, metabolomics, glycomics, and bioinformatics analysis services, Creative Proteomics has introduced its newly-updated service--targeted metabolomics to assist biotech researchers of their clientsFull story -
Accumen Launches New Website to Showcase Its Expanded Range of Technologies and Services to Optimize Healthcare Performance
Nov 20, 2019, 11:21 AM by Michael CroftPHOENIX, AZ - Nov 20, 2019 - Accumen Inc., the leader in healthcare performance, today announced the launch of its new website at wwwFull story -
Mologic launches clinical trial for validation of point-of-care COPD exacerbation alert system
Nov 20, 2019, 09:10 AM by Michael CroftBEDFORDSHIRE, UNITED KINGDOM - Nov 20, 2019 -Full story- COPE-WEL study aims to validate Headstart® test for early detection and monitoring of pulmonary exacerbation of COPD
- Headstart is a non-invasive self-test that detects lung biomarkers in the urine
- Observational, multi-centre validation trial carried out in collaboration with a consortium of leading clinicians and clinical centres
-
Will Organ-On-A-Chip Models Be Viable Alternatives to Animal Testing?
Nov 20, 2019, 07:50 AM by Michael CroftFull storyBio-IT World | A new testing technology is of great interest to pharmaceutical companies looking to better understand the effects of medicines—especially the unintended consequences of their administration—and will facilitate study of not only toxicity, but also the mechanism by which drugs work and the timing of their delivery and physiological response.
-
Optibrium collaborates with Enamine and BioSolveIT to add REAL Space Search Tool to StarDrop
Nov 20, 2019, 06:06 AM by Michael CroftCAMBRIDGE, UNITED KINGDOM - Nov 19, 2019 - Optibrium, BioSolveIT and Enamine, leading providers of software and services for drug discovery, today announce a three-way collaboration enabling efficient search of Enamines REAL Space directly from within Optibriums StarDrop softwareFull story -
Creative Biolabs Announced cd25 Monoclonal Antibody for Research Use
Nov 19, 2019, 01:24 AM by Michael CroftSHIRLEY, NY - Nov 19, 2019 - November 19, 2019, as a leading supplier in the recombinant antibody field, Creative Biolabs aims to provide high-quality services and products to clients in the academia and industry fields all over the worldFull story -
ScaleMatrix’ DDC Technology Enables Enterprises to Deploy 13 PFLOP NVIDIA DGX-powered ‘AI Anywhere’ Infrastructure with Flexible, ‘No Data Center Required’ Design
Nov 18, 2019, 19:24 PM by Michael CroftDENVER, CO - Nov 18, 2019 - ScaleMatrix, through its subsidiary company, DDC, the global leader in providing scalable data center-to-edge solutions based on its patented Dynamic Density Control™ (DDC) cabinet technology, today announced that it is collaborating with NVIDIA and Microway to deliver SKUs for an 8 petaFLOPS and a 13 petaFLOPS 'Supercomputer Anywhere' solution using its DDC S-Series cabinetsxFull story